این سایت در حال حاضر پشتیبانی نمی شود و امکان دارد داده های نشریات بروز نباشند
صفحه اصلی
درباره پایگاه
فهرست سامانه ها
الزامات سامانه ها
فهرست سازمانی
تماس با ما
JCR 2016
جستجوی مقالات
دوشنبه 27 بهمن 1404
Physiology and Pharmacology
، جلد ۲۹، شماره ۴، صفحات ۳۷۵-۳۸۵
عنوان فارسی
چکیده فارسی مقاله
کلیدواژههای فارسی مقاله
عنوان انگلیسی
Serum levels of thyroid hormones change differently in the onset and progress phases of the experimental model of Parkinson’s disease in rats
چکیده انگلیسی مقاله
Introduction: Changes in the levels of serum components can help in the early and differential diagnosis of Parkinson’s disease (PD). The lesion in the dopaminergic (DAergic) system is the main pathophysiological mechanism underlying PD. This system is closely related to the hypothalamic-pituitary-thyroid axis. Here, we examined the impact of PD onset, progress, and severity in rats on the serum levels of thyroid hormones (THs). Methods: The neurotoxin 6-OHDA was injected into the medial forebrain bundle. Behavioral tests were carried out for eight weeks after the toxin to assess the severity of PD and its progress. Blood was collected before the toxin and in the third and eighth weeks afterward. THs levels were determined using specific ELISA kits. Results: Our findings show that the THs levels changed significantly after the toxin. The levels of T3 and T4 decreased slightly in the third week but remarkably increased in the eighth week. The decrease in the third week depended on the severity of the PD and was observed only in the rats with severe behavioral symptoms. On the other hand, the increase in the eighth week occurred in all 6-OHDA-received rats with severe or mild behavioral symptoms. Conclusion: Our data indicate that serum levels of THs may decrease and increase in PD. At the onset of the disease, the levels may decrease if DAergic neuronal death is severe. In the progress phase of PD, THs levels may increase independent of the severity of the disease.
کلیدواژههای انگلیسی مقاله
Parkinson’s disease, Thyroid hormones, 6-OHDA, Onset, Progress
نویسندگان مقاله
| Shahram Darabi
Non-communicable Diseases Research Center, Research Institute for Prevention of Non-Communicable Diseases, Qazvin University of Medical Sciences, Qazvin, Iran
| Hashem Haghdoost- Yazdi
Non-communicable Diseases Research Center, Research Institute for Prevention of Non-Communicable Diseases, Qazvin University of Medical Sciences, Qazvin, Iran
| Mohammad Sofiabadi
Non-communicable Diseases Research Center, Research Institute for Prevention of Non-Communicable Diseases, Qazvin University of Medical Sciences, Qazvin, Iran
| Mohammad Hossein Esmaeili
Non-communicable Diseases Research Center, Research Institute for Prevention of Non-Communicable Diseases, Qazvin University of Medical Sciences, Qazvin, Iran
| Mehrdad Delashoob
Non-communicable Diseases Research Center, Research Institute for Prevention of Non-Communicable Diseases, Qazvin University of Medical Sciences, Qazvin, Iran
نشانی اینترنتی
http://ppj.phypha.ir/browse.php?a_code=A-10-143-9&slc_lang=en&sid=1
فایل مقاله
فایلی برای مقاله ذخیره نشده است
کد مقاله (doi)
زبان مقاله منتشر شده
en
موضوعات مقاله منتشر شده
Neurophysiology/Pharmacology
نوع مقاله منتشر شده
Experimental research article
برگشت به:
صفحه اول پایگاه
|
نسخه مرتبط
|
نشریه مرتبط
|
فهرست نشریات